Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD)
NCT06474507 is an interventional trial sponsored by Tongji Hospital. As of 18 Nov 2026, it is recruiting participants. It studies Bos taurus gallstone preparation in Acute Ischemic Stroke, Cerebral Small Vessel Diseases and 1 more condition. The registry lists an enrollment of 230 participants at 2 sites in 1 country. The registry lists a start date of 8 Aug 2024 and a primary completion date of 31 Jul 2029. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT06474507 |
| Status | Recruiting |
| Study type | Interventional trial |
| Lead sponsor | Tongji Hospital |
| Enrollment | 230 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Acute Ischemic Stroke, Cerebral Small Vessel Diseases and Ischemic Cerebrovascular Disease |
| Drugs | Bos taurus gallstone preparation |
| Start | 8 Aug 2024 |
| Primary completion | 31 Jul 2029 |
| Study completion | 31 Dec 2029 |
| Last update posted | 20 Sept 2024 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tongji Hospital Affiliated To Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei
Recruiting - Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei
Recruiting
Sites by country
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT06474507
Each answer restates registry values shown on this page.
What is NCT06474507?
NCT06474507 is an interventional trial sponsored by Tongji Hospital. It studies Bos taurus gallstone preparation in Acute Ischemic Stroke, Cerebral Small Vessel Diseases and 1 more condition.
Is NCT06474507 recruiting?
As of 18 Nov 2026, it is recruiting participants. 2 of its 2 sites list their own status as recruiting.
Who leads NCT06474507?
The registry names Wei Wang, MD (principal investigator, Tongji Hospital) as the overall official.
Where does NCT06474507 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: China.
Which drugs does NCT06474507 study?
The registered drug and biological interventions are Bos taurus gallstone preparation.
When is NCT06474507 expected to complete?
The registry lists a primary completion date of 31 Jul 2029 and a study completion date of 31 Dec 2029. The sponsor last updated the record on 20 Sept 2024.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.